Midi Health review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
Midi Health charges $250 for a first visit if you self-pay and says an in-network one is covered. Its own compounded GLP-1 starts at $164 per four-week supply.
The medication figure is a floor attached to a four-week supply rather than a month, and it sits on top of a visit fee. A self-pay patient pays for the appointment first and the medication second, and the site never combines them.
- Advertised $164, actually $250
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
An insurance-first menopause practice that prices the clinician clearly and the medication barely: one floor, attached to a four-week period and three separate qualifiers.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- First visit, self-pay
- $250 for 30 minutes
- Returning visit, self-pay
- $150 for 15 minutes
- First visit, in network
- Covered, subject to your plan
- Compounded GLP-1
- From $164 per four-week supply
- Brand GLP-1 cost
- Not published; sent to your own pharmacy
- Medicare
- Out of network; self-pay only, no claims
- Medicaid and Medi-Cal
- Not accepted
- Legal entity
- Midi Health, Inc.
Pros and cons
What we like
- Publishes both visit prices with their durations, beside the insured alternative.
- States plainly which patients it cannot accept, including Medicaid and Medi-Cal.
- Says Medicare is out of network rather than leaving beneficiaries to discover it.
- Names the corporate entity and the medical groups its clinicians practise under.
- Confirms FSA and HSA funds can be used for visits and services.
- Says the compounded figure includes shipping and supplies rather than adding them later.
What could be better
- The medication figure is a floor with three qualifiers attached in one sentence.
- It is quoted per four-week supply, which is not a month and not comparable to monthly rates.
- No price at all is published for the brand GLP-1s it prescribes.
- No list of licensed states appears on any page we read.
- No compounding pharmacy is named.
What it is
Midi Health is a menopause and midlife practice that prescribes GLP-1s as one service among many, not a GLP-1 seller with a clinic attached. That difference shows in how it charges: visits are the unit of billing, insurance is the default assumption, and the site devotes a whole page to coverage rather than to price. Its terms name Midi Health, Inc., choose California law, and name the medical groups its clinicians practise under.
It is also unusually specific about who it cannot take. The pricing page states that Medicare is out of network and that Medicare beneficiaries may attend only as self-pay patients without submitting claims, and that Medicaid and Medi-Cal patients cannot be accepted at all. Sellers rarely volunteer the categories of patient they turn away.
Every price we found at Midi Health
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| First visit, self-payThirty minutes. The same row shows an in-network visit as covered, subject to the patient's own plan and deductible. | not published | $250 | not comparable | September 2026 |
| Returning visit, self-payFifteen minutes, for progress checks and care-plan adjustments. Again shown beside a covered in-network alternative. | not published | $150 | not comparable | September 2026 |
| Midi compounded GLP-1 or GLP-1 and GIPA starting price per four-week supply, not per calendar month, and stated to depend on the medication, the format and the dose. Shipping and supplies are included. | not published | $164 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs at Midi Health
Two prices for the clinician, one floor for the drug: $250 for a thirty-minute first visit self-pay, $150 for a fifteen-minute follow-up, and compounded medication from $164 per four-week supply.
The visit pricing is clean and easy to act on. Both figures are the self-pay column of a two-column table whose other column reads "Covered", so a reader can see immediately which situation they are in and what the alternative costs. FSA and HSA use is confirmed. That part of the page does its job.
The medication is where it thins out. Brand GLP-1s are sent to the patient's own pharmacy, so what they cost depends on an insurer and Midi publishes nothing — which is honest rather than evasive, given it is not the seller, though it does mean the bill turns on what a prior authorization for a GLP-1 actually hinges on. Its own compounded line does carry a figure, and that figure arrives with three qualifiers in one sentence: it starts at the number, it is per four-week supply rather than per month, and it depends on the medication, the format and the dose. Four weeks is not a month, and thirteen four-week supplies fall in a year rather than twelve, so this number is not directly comparable to a monthly rate anywhere else on this roster.
A lower-dose program is offered as well, quoted at a weekly figure in the thirties for eligible patients. It is a real published price, but it is quoted per week rather than per month, conditioned on eligibility, and belongs to a different product, so it is described here rather than recorded as a rate.
Who it's wrong for
- Medicaid and Medi-Cal patients, who its pricing page says it cannot accept.
- Medicare beneficiaries who need to claim. The page says Medicare is out of network and that no claims may be submitted.
- Anyone who wants one monthly number. Here it is a visit fee plus a medication cost quoted over four weeks.
- Anyone comparing per-month rates directly. A four-week supply is not a calendar month, and thirteen of them fall in a year.
- Anyone who needs to know their state first. No list of licensed states is published.
Medications available
- Midi compounded GLP-1 and GLP-1/GIPCompoundedFrom $164 per four-week supply
The figure depends on medication, format and dose. Shipping and supplies are included.
- Brand-name GLP-1sBrand
Sent to a pharmacy of the patient's choice. Cost depends on insurance coverage and drug price, and Midi publishes no figure.
Is Midi Health legit?
Midi Health is operated by Midi Health, Inc.. We read that off the company’s own terms and conditions on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityMidi Health, Inc.
- Governing lawCalifornia
- Medical groups namedIntegrative Women's Care PC, IWC Medical Group, P.A. and IWC Medical Group KS, P.A.
- Pharmacy namedNot disclosed
- Drug formBrand and compounded; the compounded line is not FDA-approved
- InsuranceIn network with many PPO plans; Medicare out of network
- States servedNot published
Common questions
How much is a Midi Health visit without insurance?
A thirty-minute first visit is $250 and a fifteen-minute returning visit is $150. Both are the self-pay figures; the same table shows in-network visits as covered, with what you owe depending on your own deductible and copay.
What does Midi Health charge for GLP-1 medication?
Its own compounded line starts at $164 per four-week supply, and the page says the figure depends on the medication, the format and the dose. Brand GLP-1s go to your own pharmacy and Midi publishes no price for them at all.
Is a four-week supply the same as a month at Midi Health?
No, and the difference compounds. Thirteen four-week supplies fall in a year rather than twelve, so a figure quoted per four weeks is not directly comparable with a monthly rate published by another seller.
Does Midi Health take Medicare or Medicaid?
Its pricing page says Medicare is out of network, that beneficiaries are welcome only as self-pay patients and cannot submit claims for anything related to a Midi visit, and that Medicaid and Medi-Cal patients cannot be accepted at this time.
Who provides the clinical care at Midi Health?
Its terms name the medical groups directly: Integrative Women's Care PC, IWC Medical Group, P.A. and IWC Medical Group KS, P.A. The corporate entity behind the platform is named separately as Midi Health, Inc.
Why we gave Midi Health a C
Read the full grading rationale
Midi Health is a menopause practice that prescribes GLP-1s rather than a GLP-1 seller, and it prices like one: a thirty-minute first visit is $250 self-pay and a fifteen-minute follow-up is $150, with a whole page devoted to which insurers it is in network with and what happens if yours is not. That page is unusually honest about its own limits — it states plainly that Medicare is out of network and that Medicaid and Medi-Cal patients cannot be accepted at all, which is the sort of exclusion most sellers leave for the reader to discover. Where it falls to a C is the medication, which is the thing a reader comparing this against the rest of the roster actually wants to know. Brand GLP-1s are sent to your own pharmacy and priced by your insurer, so Midi publishes no figure for them. Its own compounded line carries one number, and that number is a floor attached to a period that is not a month: "Starts at $164 per 4-week supply, depending on medication, format, and dose." Three qualifiers on one figure, and thirteen four-week supplies in a year rather than twelve. It names the corporate entity and the three medical groups its clinicians practise under, which is more disclosure than most of this lane, and it publishes no list of the states it is licensed in.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed Midi Health
- We read the pricing and insurance page, the weight-management page, the homepage and the terms and conditions in full on 2026-09-12, and took each figure from the page that prints it.
- A nonsense path on the same host in the same session returned a discriminating HTTP 404, so a 200 on this host carries information.
- The two visit figures are recorded as per-visit charges and not as monthly medication prices, because that is what they are. Publishing a visit fee as a monthly rate would tell a reader this practice is cheaper than it is.
- The lower-dose weekly figure is described in words rather than recorded as a rate: it is quoted per week, conditioned on eligibility, and belongs to a different product from the one this review prices.
- The FDA warning-letter screen ran on the company's own domain, with a known-positive and a known-negative control passing in the same run. It returned no candidate letters, and no postal address is published, so the address half could never have run.
The 2 pages we read — all on
- Weight management page
Starts at $164 per 4-week supply, depending on medication, format, and dose. Price includes shipping and supplies, and orders ship discreetly.
- Pricing insurance page
First Visit Insurance Self-pay 30-minutes. We'll dig into your symptoms, health history, and goals, then build a care plan tailored to you. Covered $250
This link pays us nothing. It's here because the price is checkable.
Alternatives to Midi Health
| Provider | Grade | Cheapest price |
|---|---|---|
| AM Rx | CCaveat | $151/mo |
| Arc-1 | FFail | $149/mo |
| Auren Rx | BMinor gap | $149/mo |
| Coivas | CCaveat | $149/mo |
| Corsica Health | CCaveat | $149/mo |